BAZ1A antibody
Principal name
BAZ1A antibody
Alternative names for BAZ1A antibody
ACF1, WCRF180, HSPC317, Bromodomain adjacent to zinc finger domain protein 1A, ATP-utilizing chromatin assembly and remodeling factor 1, ATP-dependent chromatin-remodeling protein, Williams syndrome transcription factor-related chromatin-remodeling factor 180, CHRAC subunit ACF1
Gene ID
11177 (BAZ1A)
Ncbi ID
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Immunocytochemistry/Immunofluorescence (ICC/IF), Immunoprecipitation (IP), Paraffin Sections (P)
Background of BAZ1A antibody
Bromodomain adjacent to zinc finger domain protein 1A is a protein that in humans is encoded by the BAZ1A gene. Component of the ACF complex, an ATP-dependent chromatin remodeling complex, that regulates spacing of nucleosomes using ATP to generate evenly spaced nucleosomes along the chromatin. The ATPase activity of the complex is regulated by the length of flanking DNA. Also involved in facilitating the DNA replication process. BAZ1A is the accessory, non-catalytic subunit of the complex which can enhance and direct the process provided by the ATPase subunit, SMARCA5, probably through targeting pericentromeric heterochromatin in late S phase.
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA350729 | BAZ1A antibody |
||||||
| Rabbit Polyclonal Anti-BAZ1A Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC214623L2V | Lenti ORF particles, BAZ1A (mGFP-tagged) - Human bromodomain adjacent to zinc finger domain, 1A (BAZ1A), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,680.00
|
|
| OriGene Technologies, Inc. | ||
| RC214623L1V | Lenti ORF particles, BAZ1A (Myc-DDK tagged) - Human bromodomain adjacent to zinc finger domain, 1A (BAZ1A), transcript variant 1 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,420.00
|
|
| OriGene Technologies, Inc. | ||